- Home
- AMBI vs ADCT Comparison
AMBI vs ADCT Comparison
Compare AMBI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- ADCT
- Stock Information
- Founded
- AMBI 1995
- ADCT 2011
- Country
- AMBI Brazil
- ADCT Switzerland
- Employees
- AMBI N/A
- ADCT N/A
- Industry
- AMBI Environmental Services
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- ADCT Health Care
- Exchange
- AMBI Nasdaq
- ADCT Nasdaq
- Market Cap
- AMBI 321.5M
- ADCT 285.2M
- IPO Year
- AMBI N/A
- ADCT 2020
- Fundamental
- Price
- AMBI $5.27
- ADCT $1.98
- Analyst Decision
- AMBI
- ADCT Strong Buy
- Analyst Count
- AMBI 0
- ADCT 5
- Target Price
- AMBI N/A
- ADCT $7.33
- AVG Volume (30 Days)
- AMBI 15.7K
- ADCT 437.2K
- Earning Date
- AMBI 01-01-0001
- ADCT 11-07-2024
- Dividend Yield
- AMBI N/A
- ADCT N/A
- EPS Growth
- AMBI 3161.09
- ADCT N/A
- EPS
- AMBI 0.56
- ADCT N/A
- Revenue
- AMBI $504,573,816.00
- ADCT $70,717,000.00
- Revenue This Year
- AMBI N/A
- ADCT $6.66
- Revenue Next Year
- AMBI N/A
- ADCT $16.38
- P/E Ratio
- AMBI $9.04
- ADCT N/A
- Revenue Growth
- AMBI 25.13
- ADCT N/A
- 52 Week Low
- AMBI $3.07
- ADCT $0.69
- 52 Week High
- AMBI $8.44
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- AMBI 45.44
- ADCT 25.90
- Support Level
- AMBI $4.84
- ADCT $1.89
- Resistance Level
- AMBI $5.97
- ADCT $3.06
- Average True Range (ATR)
- AMBI 0.81
- ADCT 0.23
- MACD
- AMBI -0.16
- ADCT -0.11
- Stochastic Oscillator
- AMBI 31.54
- ADCT 8.83
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.